CT
LABD icon

CMT Trading’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

CMT Trading’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-8
Closed -$72K – 17
2017
Q4 		$72K Sell
8
-1
-11% -$9.96K 0.1% 19
2017
Q3 		$86K Sell
9
-2
-18% -$24.1K 0.14% 21
2017
Q2 		$145K Buy
11
+3
+38% +$57.6K 0.29% 28
2017
Q1 		$167K Buy
8
+1
+14% +$24.7K 0.23% 33
2016
Q4 		$256K Buy
+7
New +$269K 0.31% 24
2015
Q4 		– Sell
-3
Closed -$286K – 23
2015
Q3 		$286K Buy
+3
New +$212K 1.17% 27

Other funds holding LABD

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CMT Trading's LABD Position: Q1 2018 in Review

CMT Trading sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q1 2018, closing a stake of 8 shares — an estimated $72K sold.

CMT Trading first reported a position in LABD in Q3 2015 and held it in 6 quarters. The position peaked at $286K in Q3 2015. 11 funds tracked by Wall St. Rank hold LABD as of Q1 2018.

  • CMT Trading reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q1 2018 after selling out during the quarter.
  • CMT Trading sold 8 Direxion Daily S&P Biotech Bear 3X ETF shares in Q1 2018, an estimated $72K.
  • CMT Trading first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q3 2015 and held it in 6 quarters.
  • CMT Trading's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $286K in Q3 2015.
  • 11 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q1 2018.

Based on CMT Trading's 13F filing for Q1 2018, filed 15 May 2018.